The DOI matches its Crossref record; 765 of the 770 references it cites were found in a registry or an index.
The epigenetics of aging and neurodegeneration
Open accessAbstract
Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and non-coding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the cellular heterogeneity of the AD brain presents significant analytical hurdles. Advanced computational deconvolution techniques or experimental methods such as fluorescence-activated cell sorting (FACS) are often required to resolve distinct cell populations, including neurons, astrocytes, and microglia127,157.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 401–600 of 765
Podlisny, M. B., Tolan, D. R., & Selkoe, D. J. (1991) · PubMed Central · Cited by 217
Sustained effects of nonallele‐specific Huntingtin silencing
Drouet, V., Perrin, V., Hässig, R., Dufour, N., Aurégan, G., Alves, S., Bonvento, G., Brouillet, E., Luthi‐Carter, R., Hantraye, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21569 · Cited by 217
Protein Phosphatase 1 Regulates the Histone Code for Long-Term Memory
Koshibu, K., Gräff, J., Beullens, M., Heitz, F. D., Berchtold, D., Russig, H., Farinelli, M., Bollen, M., & Mansuy, I. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3610-09.2009 · Cited by 216
Morse, D. P., Aruscavage, P. J., & Bass, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112704299 · Cited by 215
Mohamed, J. S., Lopez, M. A., & Boriek, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101147 · Cited by 214
Song, C., Kanthasamy, A., Anantharam, V., Sun, F., & Kanthasamy, A. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.062174 · Cited by 214
Benefit of valproic acid in suppressing disease progression of ALS model mice
Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z., Sumi, H., Hamasaki, T., Goto, M., & Sakoda, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03765.x · Cited by 214
Tissue‐specific dysregulation of DNA methylation in aging
Thompson, R. F., Atzmon, G., Gheorghe, C. P., Liang, H. Q., Lowes, C., Greally, J. M., & Barzilai, N. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00577.x · Cited by 213
Hypomethylation of the amyloid precursor protein gene in the brain of an alzheimer’s disease patient
West, R. L., Lee, J. M., & Maroun, L. E. (1995) · Journal of Molecular Neuroscience · doi:10.1007/bf02736773 · Cited by 213
Non‐coding RNAs: biological functions and applications
Santosh, B., Varshney, A., & Yadava, P. K. (2014) · Cell Biochemistry and Function · doi:10.1002/cbf.3079 · Cited by 212
The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases
Lahiri, D. K., Maloney, B., & Zawia, N. H. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.82 · Cited by 212
Long, J. M., & Lahiri, D. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.053 · Cited by 211
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
DNA methylation in repetitive elements and Alzheimer disease
Bollati, V., Galimberti, D., Pergoli, L., Valle, E. D., Barretta, F., Cortini, F., Scarpini, E. A., Bertazzi, P. A., & Baccarelli, A. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.017 · Cited by 211
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Sadri‐Vakili, G., Bouzou, B., Benn, C., Kim, M.-O., Chawla, P., Overland, R. P., Glajch, K. E., Xia, E., Qiu, Z., Hersch, S. M., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm078 · Cited by 210
Bujnicki, J. M., Feder, M., Radlińska, M., & Blumenthal, R. (2002) · Journal of Molecular Evolution · doi:10.1007/s00239-002-2339-8 · Cited by 210
Effect of aging on 5-hydroxymethylcytosine in brain mitochondria
Dzitoyeva, S., Chen, H., & Manev, H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.006 · Cited by 209
MicroRNAs can regulate human APP levels
Patel, N., Hoang, D. M., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., Lee, J. C., & Saunders, A. J. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-10 · Cited by 209
Wood, M. A., Attner, M. A., Oliveira, A. M. M., Brindle, P. K., & Abel, T. G. (2006) · Learning & Memory · doi:10.1101/lm.213906 · Cited by 207
Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011) · Aging · doi:10.18632/aging.100285 · Cited by 207
Olivieri, F., Lazzarini, R., Recchioni, R., Marcheselli, F., Rippo, M. R., Nuzzo, S., Albertini, M. C., Graciotti, L., Babini, L., Mariotti, S., et al. (2012) · AGE · doi:10.1007/s11357-012-9440-8 · Cited by 206
MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1
Zhu, H.-C., Wang, L.-M., Wang, M., Song, B., Tan, S., Teng, J.-F., & Duan, D.-X. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.018 · Cited by 204
Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation.
Reis, R. J. S., & Goldstein, S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44633-3 · Cited by 203
Functional Analyses of the Transcription Factor Sp4 Reveal Properties Distinct from Sp1 and Sp3
Hagen, G., Dennig, J., Preiß, A., Beato, M., & Suske, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24989 · Cited by 203
Jackman, J. E., Montange, R. K., Malik, H. S., & Phizicky, E. M. (2003) · RNA · doi:10.1261/rna.5070303 · Cited by 203
Dnmt2 functions in the cytoplasm to promote liver, brain, and retina development in zebrafishPreprint
Rai, K., Chidester, S., Zavala, C. V., Manos, E. J., James, S. R., Karpf, A. R., Jones, D. A., & Cairns, B. R. (2007) · Genes & Development · doi:10.1101/gad.1472907 · Cited by 201
Schmitz, K., Schmitt, N., Hoffmann‐Rohrer, U., Schäfer, A., Grummt, I., & Mayer, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.015 · Cited by 199
St. Laurent, R., O’Brien, L. M., & Ahmad, S. T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.037 · Cited by 199
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Epigenetic changes in the progression of Alzheimer's disease
Bradley‐Whitman, M. A., & Lovell, M. A. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.005 · Cited by 198
Trapp, J., Meier, R., Hongwiset, D., Kassack, M. U., Sippl, W., & Jung, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700003 · Cited by 198
Fuso, A., Nicolia, V., Cavallaro, R. A., Ricceri, L., D’Anselmi, F., Coluccia, P., Calamandrei, G., & Scarpa, S. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.018 · Cited by 197
Presenilin 1 gene silencing by S ‐adenosylmethionine: a treatment for Alzheimer disease?
Scarpa, S., Fuso, A., D’Anselmi, F., & Cavallaro, R. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00277-1 · Cited by 196
Formation and development of Lewy pathology: a critical update
Jellinger, K. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5243-y · Cited by 195
Ferrante, R. J., Ryu, H., Kubilus, J. K., D’Mello, S. R., Sugars, K. L., Lee, J.-H., Lu, P., Smith, K., Browne, S. E., Beal, M. F., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2599-04.2004 · Cited by 195
Targeted proteomics for quantification of histone acetylation in A lzheimer's disease
Zhang, K., Schrag, M., Crofton, A. R., Trivedi, R. K., Vinters, H. V., & Kirsch, W. M. (2012) · PROTEOMICS · doi:10.1002/pmic.201200010 · Cited by 195
Murine microRNAs implicated in liver functions and aging process
Maes, O. C., An, J., Sarojini, H., & Wang, E. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.05.004 · Cited by 193
Liu, W., Chang, L., Zhu, J.-X., Shu, P., Yin, B., Gong, Y., Qiang, B., Yuan, J., & Peng, X. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.034 · Cited by 193
DNA Methylation of Alzheimer Disease and Tauopathy-Related Genes in Postmortem Brain
Barrachina, M., & Ferrer, I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181af2e46 · Cited by 192
miR-146a is modulated in human endothelial cell with aging
Vasa‐Nicotera, M., Chen, H., Tucci, P., Yang, A. L., Saintigny, G., Menghini, R., Mahé, C., Agostini, M., Knight, R. A., Melino, G., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.034 · Cited by 192
Amino-terminal sequence identity of ubiquitin and the nonhistone component of nuclear protein A24
Hunt, L. T., & Dayhoff, M. O. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90352-7 · Cited by 190
MicroRNAs in neurodegenerative diseases and their therapeutic potential
Junn, E., & Mouradian, M. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.002 · Cited by 186
Extensive changes in DNA methylation are associated with expression of mutant huntingtin
Ng, C., Yildirim, F., Yap, Y. S., Dalin, S., Matthews, B. J., Vélez, P., Labadorf, A. T., Housman, D. E., & Fraenkel, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221292110 · Cited by 185
Boulias, K., & Horvitz, H. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.014 · Cited by 184
Wang, W., Wilfred, B. R., Madathil, S. K., Tang, G., Hu, Y., Dimayuga, J., Stromberg, A. J., Huang, Q., Saatman, K. E., & Nelson, P. T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091202 · Cited by 183
Zhou, W., Bercury, K. K., Cummiskey, J., Luong, N., Lebin, J. A., & Freed, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211029 · Cited by 183
MicroRNAs with a nucleolar location
Politz, J. C. R., Hogan, E. M., & Pederson, T. (2009) · RNA · doi:10.1261/rna.1470409 · Cited by 183
Akbarian, S., Smith, M. A., & Jones, E. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00922-d · Cited by 183
Smith, P., Al Hashimi, A., Girard, J., Delay, C., & Hébert, S. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07097.x · Cited by 182
Genetics and Epigenetics of Parkinson's Disease
Coppedè, F. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/489830 · Cited by 182
Siddiqui, A., Chinta, S. J., Mallajosyula, J. K., Rajagopolan, S., Hanson, I. M., Rane, A., Melov, S., & Andersen, J. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.024 · Cited by 182
Tau – an inhibitor of deacetylase HDAC6 function
Perez, M., Santa‐Maria, I., De Barreda, E. G., Zhu, X., Cuadros, R., Cabrero, J. R., Sanchez‐Madrid, F., Dawson, H. N., Vitek, M. P., Perry, G., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06102.x · Cited by 182
Hutnick, L. K., Golshani, P., Namihira, M., Xue, Z., Matynia, A., Yang, X. W., Silva, A. J., Schweizer, F. E., & Fan, G. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp222 · Cited by 181
Orr, B. A., Haffner, M. C., Nelson, W. G., Yegnasubramanian, S., & Eberhart, C. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041036 · Cited by 180
de Groote, M. L., Verschure, P. J., & Rots, M. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks863 · Cited by 180
Two related ARID family proteins are alternative subunits of human SWI/SNF complexes
Xiaomei, W. A. N. G., Nagl, N. G., Wilsker, D. F., Scoy, M. V., Pacchione, S. J., Yaciuk, P., Dallas, P. B., & Morán, E. (2004) · Biochemical Journal · doi:10.1042/bj20040524 · Cited by 178
Human DNMT2 methylates tRNAAsp molecules using a DNA methyltransferase-like catalytic mechanism
Jurkowski, T. P., Meusburger, M., Phalke, S., Helm, M., Nellen, W., Reuter, G., & Jeltsch, A. (2008) · RNA · doi:10.1261/rna.970408 · Cited by 178
Variant TREM2 as Risk Factor for Alzheimer's Disease
Neumann, H., & Daly, M. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1213157 · Cited by 177 · cited 2×
“The same applies to the rare mutations recently discovered in the triggering receptor expressed on myeloid cells 2 (TREM2) gene, although they confer a much larger increase in risk to develop sAD than the common sequence variants (Guerreiro et al., 2013; Jonsson et al., 2013; Neumann and Daly, 2013).”
BackgroundChatterjee, S., Mizar, P., Cassel, R., Neidl, R., Selvi, B. R., Mohankrishna, D. V., Vedamurthy, B. M., Schneider‐Anthony, A., Bousiges, O., Mathis, C., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5772-12.2013 · Cited by 177
Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficitsPreprint
Oliveira, A. M. M., Wood, M. A., McDonough, C. B., & Abel, T. G. (2007) · Learning & Memory · doi:10.1101/lm.656907 · Cited by 177
Ye, X., Zerlanko, B. J., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 177
Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Ogawa, O., Zhu, X., Lee, H., Raina, A. K., Obrenovich, M. E., Bowser, R. P., Ghanbari, H. A., Castellani, R. J., Perry, G. L., & Smith, M. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0684-3 · Cited by 175
The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule
Carrettiero, D. C., Hernández, I., Neveu, P. A., Papagiannakopoulos, T. Y., & Kosik, K. S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4660-08.2009 · Cited by 175
Hong, E. E., Okitsu, C. Y., Smith, A. D., & Hsieh, C.-L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00220-13 · Cited by 175
Genome-wide association between DNA methylation and alternative splicing in an invertebrate
Flores, K., Wolschin, F., Corneveaux, J. J., Allen, A. N., Huentelman, M. J., & Amdam, G. V. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-480 · Cited by 174
The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy
Yu, J.-T., & Tan, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8237-1 · Cited by 174
High-Resolution Enzymatic Mapping of Genomic 5-Hydroxymethylcytosine in Mouse Embryonic Stem Cells
Sun, Z., Terragni, J., Borgaro, J. G., Liu, Y., Yu, L., Guan, S., Wang, H., Sun, D., Cheng, X., Zhu, Z., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.001 · Cited by 173
Jia, H., Pallos, J., Jacques, V., Lau, A., Tang, B., Cooper, A. C., Syed, A., Purcell, J. M., Chen, Y., Sharma, S., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.016 · Cited by 173
P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease
Lafaille‐Magnan, M., Breitner, J. C. S., Etienne, P. E., Poirier, J., Fontaine, D. J., Rosa‐Neto, P., & Rajah, N. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.383 · Cited by 172
β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
Abeti, R., Abramov, A. Y., & Duchen, M. R. (2011) · Brain · doi:10.1093/brain/awr104 · Cited by 172
Zhu, B. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4157 · Cited by 172
Iskandar, B. J., Rizk, E., Meier, B. M., Hariharan, N., Bottiglieri, T., Finnell, R. H., Jarrard, D. F., Banerjee, R. V., Skene, J. H. P., Nelson, A. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40000 · Cited by 171
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes
Myung, N.-H., Zhu, X., Kruman, I. I., Castellani, R. J., Petersen, R. B., Siedlak, S. L., Perry, G., Smith, M. A., & Lee, H.-G. (2008) · AGE · doi:10.1007/s11357-008-9050-7 · Cited by 170
Histone deacetylases 1 and 2 are expressed at distinct stages of neuro‐glial development
MacDonald, J. L., & Roskams, A. J. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21626 · Cited by 169
Maurice, T., Duclot, F., Meunier, J., Naert, G., Givalois, L., Meffre, J., Célérier, A., Jacquet, C., Copois, V., Mechti, N., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301551 · Cited by 169
Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 169
ADAR Gene Family and A-to-I RNA Editing: Diverse Roles in Posttranscriptional Gene Regulation
Valente, L., & Nishikura, K. (2005) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)79006-6 · Cited by 168
Egorin, M. J., Yuan, Z.-M., Sentz, D. L., Plaisance, K. I., & Eiseman, J. L. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050922 · Cited by 166
RNA traffic control of chromatin complexes
Koziol, M. J., & Rinn, J. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.003 · Cited by 164
Jin, H., Kanthasamy, A., Ghosh, A., Yang, Y., Anantharam, V., & Kanthasamy, A. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5634-10.2011 · Cited by 164
DNA methylation based biomarkers: Practical considerations and applications
Kit, A. H., Nielsen, H. M., & Tost, J. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.014 · Cited by 163
Schönrock, N., Humphreys, D. T., Preiß, T., & Götz, J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9587-2 · Cited by 163
Mielcarek, M., Benn, C., Franklin, S., Smith, D. L., Woodman, B., Marks, P. A., & Bates, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027746 · Cited by 163
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment
Huynh, J. L., & Casaccia, P. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70309-5 · Cited by 162
Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms
Czech, C., Tremp, G. L., & Pradier, L. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00033-7 · Cited by 160
Franich, N. R., Fitzsimons, H. L., Fong, D. M., Klugmann, M., During, M. J., & Young, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.50 · Cited by 160
Anderson, J. T., Phan, L. D., & Hinnebusch, A. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090102597 · Cited by 159
Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus
Zhang, C.-E., Tian, Q., Wei, W., Peng, J.-H., Liu, G., Zhou, X., Wang, Q., Wang, D. W., & Wang, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.015 · Cited by 159
Lopatina, N., Haskell, J. F., Andrews, L. G., Poole, J. C., Saldanha, S. N., & Tollefsbol, T. O. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10015 · Cited by 157
Brami‐Cherrier, K., Roze, E. F., Girault, J., Bétuing, S., & Caboche, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05879.x · Cited by 156
Harms, K. L., & Chen, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4397 · Cited by 156
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
Brahe, C., Vitali, T., Tiziano, F. D., Angelozzi, C., Pinto, A. M., Borgo, F., Moscato, U., Bertini, E., Mercuri, E. M., & Neri, G. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201320 · Cited by 156
The steroid receptor RNA activator is the first functional RNA encoding a protein
Chooniedass, S., Emberley, E. D., Hamedani, M. K., Troup, S., Wang, X., Czosnek, A., Hubé, F., Mutawe, M. M., Watson, P. H., & Leygue, E. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.104 · Cited by 151
Perry, M., & Chalkley, R. G. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34382-5 · Cited by 150
Bates, E. A., Victor, M., Jones, A. K., Shi, Y., & Hart, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3344-05.2006 · Cited by 149
RNA editing, DNA recoding and the evolution of human cognition
Mattick, J. S., & Mehler, M. F. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.003 · Cited by 148
Jia, H., Kast, R. J., Steffan, J. S., & Thomas, E. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds379 · Cited by 146
Impaired Social Cognition in Mild Alzheimer Disease
Bediou, B., Ryff, I., Mercier, B., Milliery, M., Hénaff, M., d’Amato, T., Bonnefoy, M., Vighetto, A., & Krolak‐Salmon, P. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709332939 · Cited by 145
Roy, A., Ghosh, A., Jana, A., Liu, X., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038113 · Cited by 145
Zhu, B., Zheng, Y., Heß, D., Angliker, H., Schwarz, S., Siegmann, M., Thiry, S., & Jost, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100107597 · Cited by 145
Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
Lunnon, K., Ibrahim, Z. M., Proitsi, P., Lourdusamy, A., Newhouse, S., Sattlecker, M., Furney, S. J., Saleem, M., Soininen, H. S., Kłoszewska, I., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111592 · Cited by 145
Persengiev, S. P., Kondova, I. I., Otting, Ń., Koeppen, A. H., & Bontrop, R. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.014 · Cited by 145
The nucleotide sequence of nuclear U6 (4.7 S) RNA.
Epstein, P. N., Reddy, R., Henning, D., & Busch, H. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43587-9 · Cited by 145
Hsieh, J., & Eisch, A. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.008 · Cited by 144
Villar-Menéndez, I., Blanch, M., Tyebji, S., Pereira‐Veiga, T., Albasanz, J. L., Martı́n, M., Ferrer, I., Pérez‐Navarro, E., & Barrachina, M. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8219-0 · Cited by 144
Chen, K.-L., Wang, S. S., Yang, Y.-Y., Yuan, R.-Y., Chen, R.-M., & Hu, C.-J. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2008.10.173 · Cited by 144
How Safe Are Folic Acid Supplements?
Campbell, N. R. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140058005 · Cited by 144
Regulation of the HIF-1α stability by histone deacetylases
Kim, S. H., Jeong, J.-W., Park, J. Y., Lee, J., Seo, J., Jung, B., Bae, M., & Kim, K. (2007) · Oncology Reports · doi:10.3892/or.17.3.647 · Cited by 144
Nass, M. M. K. (1973) · Journal of Molecular Biology · doi:10.1016/0022-2836(73)90239-8 · Cited by 141
Li, N., Bates, D. J., An, J., Terry, D. A., & Wang, E. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.020 · Cited by 141
Francis, P. T., & Perry, E. K. (2007) · Movement Disorders · doi:10.1002/mds.21683 · Cited by 140
Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy
Wang, J., Yu, J., Tan, M., Jiang, T., & Tan, L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.003 · Cited by 140
Fuso, A., Nicolia, V., Ricceri, L., Cavallaro, R. A., Isopi, E., Mangia, F., Fiorenza, M. T., & Scarpa, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.013 · Cited by 139
Histone deacetylase inhibitors: insights into mechanisms of lethality
Rosato, R. R., & Grant, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.809 · Cited by 138
Kennedy, B. P., Bottiglieri, T., Arning, E., Ziegler, M. G., Hansen, L. A., & Masliah, E. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0096-5 · Cited by 138
Espada, J., Ballestar, E., Santoro, R., Fraga, M. F., Villar‐Garea, A., Németh, A., Lopez-Serra, L., Ropero, S., Aranda, A., Orozco, H., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm118 · Cited by 137
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy
Smith, P. Y., Delay, C., Girard, J., Papon, M.-A., Planel, E., Sergeant, N., Buée, L., & Hébert, S. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr330 · Cited by 136
Massone, S., Ciarlo, E., Vella, S., Nizzari, M., Florio, T., Russo, C., Cancedda, R., & Pagano, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.001 · Cited by 136
Haplotype-specific expression of exon 10 at the human MAPT locus
Caffrey, T. M., Joachim, C. L., Paracchini, S., Esiri, M. M., & Wade‐Martins, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl429 · Cited by 135
Detection of RNA modifications
Kellner, S. M., Burhenne, J., & Helm, M. (2010) · RNA Biology · doi:10.4161/rna.7.2.11468 · Cited by 134
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
Delay, C., Calon, F., Mathews, P. M., & Hébert, S. S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-70 · Cited by 133
Genome-wide analysis of N 1 -methyl-adenosine modification in human tRNAs
Saikia, M., Fu, Y., Pavon-Eternod, M., He, C., & Pan, T. (2010) · RNA · doi:10.1261/rna.2057810 · Cited by 133
Allele-specific methylation in the human genome: Implications for genetic studies of complex disease
Meaburn, E. L., Schalkwyk, L. C., & Mill, J. (2010) · Epigenetics · doi:10.4161/epi.5.7.12960 · Cited by 132
Marinova, Z., Ren, M., Wendland, J. R., Leng, Y., Liang, M., Yasuda, S., Leeds, P. R., & Chuang, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06385.x · Cited by 132
Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation
Cook, C. N., Gendron, T. F., Scheffel, K., Carlomagno, Y., Dunmore, J. H., Deture, M. A., & Petrucelli, L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds125 · Cited by 132
Song, C., Kanthasamy, A. G., Jin, H., Anantharam, V., & Kanthasamy, A. G. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.05.018 · Cited by 131
Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain
Condliffe, D., Wong, A., Troakes, C., Proitsi, P., Patel, Y., Chouliaras, L., Fernandes, C., Cooper, J., Lovestone, S., Schalkwyk, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.002 · Cited by 131
Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y. M., Ma, C., Huang, L. J., Zhang, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.023 · Cited by 130
MicroRNAs and deregulated gene expression networks in neurodegeneration
Sonntag, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.106 · Cited by 130
MicroRNA Expression and Regulation in Human, Chimpanzee, and Macaque Brains
Hu, H. Y., Guo, S., Xi, J., Yan, Z., Fu, N., Zhang, X., Menzel, C., Liang, H., Yang, H., Zhao, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002327 · Cited by 130
Remington, R., Chan, A., Paskavitz, J., & Shea, T. B. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508325094 · Cited by 129
The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
Sleegers, K., Lambert, J.-C., Bertram, L., Cruts, M., Amouyel, P., & Van Broeckhoven, C. (2010) · Trends in Genetics · doi:10.1016/j.tig.2009.12.004 · Cited by 129
Laser Capture Microdissection of Single Cells from Complex Tissues
Suarez‐Quian, C. A., Goldstein, S. R., Pohida, T. J., Smith, P. D., Peterson, J. I., Wellner, E., Ghany, M. G., & Bonner, R. F. (1999) · BioTechniques · doi:10.2144/99262rr03 · Cited by 129
Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., & Shea, T. B. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508325093 · Cited by 127
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse
Machida, Y., Okada, T., Kurosawa, M., Oyama, F., Ozawa, K., & Nukina, N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.141 · Cited by 127
Loss of HDAC5 Impairs Memory Function: Implications for Alzheimer's Disease
Agís‐Balboa, R. C., Pavelka, Z., Kerimoglu, C., & Fischer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121009 · Cited by 127
Natural occurrence of poly(ADP-ribosyl) histones in rat liver.
Ueda, K., Omachi, A., Kawaichi, M., & Hayaishi, O. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.205 · Cited by 127
Jung, J., Lee, S., Seo, M., Park, S., Kurtz, A., Kang, S., & Kang, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0242-9 · Cited by 127
Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency
Fuso, A., Nicolia, V., Pasqualato, A., Fiorenza, M. T., Cavallaro, R. A., & Scarpa, S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.013 · Cited by 126
Chatterjee, S., Zaman, K., Ryu, H., Conforto, A. B., & Ratan, R. R. (2001) · Annals of Neurology · doi:10.1002/ana.71.abs · Cited by 126
Zhang, Z., & Schluesener, H. J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318283114a · Cited by 125
Lukiw, W. J., Handley, P., Wong, L. J., & McLachlan, D. R. C. (1992) · Neurochemical Research · doi:10.1007/bf00968788 · Cited by 125
Hébert, S. S., Wang, W.-X., Zhu, Q., & Nelson, P. T. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122350 · Cited by 125
Lombardi, M. S., Jaspers, L., Spronkmans, C., Gellera, C., Taroni, F., Maria, E. D., Donato, S. D., & Kaemmerer, W. F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.004 · Cited by 124
Enrichment for Histone H3 Lysine 9 Methylation at Alu Repeats in Human Cells
Kondo, Y., & Issa, J. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304072200 · Cited by 122
Majello, B., Luca, P. D., Suske, G., & Lania, L. (1995) · PubMed · Cited by 122
Epigenetically regulated microRNAs in Alzheimer's disease
van den Hove, D., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J. S., Steinbusch, H. W. M., Lesch, K., Fitzsimons, C. P., Strooper, B. D., & Rutten, B. P. F. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.082 · Cited by 121
Self-citationHippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease
Gaisler‐Salomon, I., Kravitz, E., Feiler, Y., Safran, M., Biegon, A. R., Amariglio, N., & Rechavi, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.018 · Cited by 121
Depletion of wild‐type huntingtin in mouse models of neurologic diseases
Zhang, Y., Li, M., Drozda, M., Chen, M., Ren, S., Sanchez, R. O. M., Leavitt, B. R., Cattaneo, E. F., Ferrante, R. J., Hayden, M. R., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01980.x · Cited by 120
Modulation of nucleosome dynamics in Huntington's disease
Stack, E. C., Signore, S. J. D., Luthi‐Carter, R., Soh, B. Y., Goldstein, D. R., Matson, S. A., Goodrich, S., Markey, A., Cormier, K., Hagerty, S. W., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm064 · Cited by 119
Methylation and acetylation in nervous system development and neurodegenerative disorders
Mattson, M. P. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00013-8 · Cited by 119
Pidsley, R., & Mill, J. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.029 · Cited by 118
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
miR-29c regulates BACE1 protein expression
Zong, Y., Wang, H., Dong, W., Quan, X., Zhu, H., Xu, Y., Huang, L., Ma, C., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.035 · Cited by 117
Stilling, R. M., Benito, E., Barth, J., Gertig, M., Capece, V., Burckhardt, S., Bonn, S., & Fischer, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00373 · Cited by 115
The potential of epigenetic therapies in neurodegenerative diseases
Coppedè, F. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00220 · Cited by 115
Aging and epigenetics: Longitudinal changes in gene-specific DNA methylation
Madrigano, J., Baccarelli, A., Mittleman, M. A., Sparrow, D., Vokonas, P., Tarantini, L., & Schwartz, J. D. (2012) · Epigenetics · doi:10.4161/epi.7.1.18749 · Cited by 114
Mouse Models of Alzheimer's Disease: Insight into Treatment
German, D. C., & Eisch, A. J. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.5.353 · Cited by 114
Fischer, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.038 · Cited by 113
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition
Kidd, S. K., & Schneider, J. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.041 · Cited by 113
Walker, M. P., LaFerla, F. M., Oddo, S., & Brewer, G. J. (2012) · AGE · doi:10.1007/s11357-011-9375-5 · Cited by 112
RNA Editing Genes Associated with Extreme Old Age in Humans and with Lifespan in C. elegans
Paola Sebastiani, B., Montano, M. A., Puca, A. A., Solovieff, N., Kojima, T., Wang, M. C., Melista, E., Meltzer, M., Fischer, S. E. J., Andersen, S. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008210 · Cited by 111
Liang, C., Zhu, H., Xu, Y., Huang, L. J., Ma, C., Deng, W., Liu, Y. M., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.051 · Cited by 111
Use of Specific Chemical Reagents for Detection of Modified Nucleotides in RNA
Behm‐Ansmant, I., Helm, M., & Motorin, Y. (2011) · Journal of Nucleic Acids · doi:10.4061/2011/408053 · Cited by 110
Age-associated decrease of SIRT1 expression in rat hippocampus
Quintas, A., de Solís, A. J., Díez-Guerra, F. J., Carrascosa, J. M., & Bogónez, E. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.010 · Cited by 110
Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease
Strosznajder, J. B., Czapski, G. A., Adamczyk, A., & Strosznajder, R. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8258-9 · Cited by 109
Neuronal apoptosis induced by histone deacetylase inhibitors
Salminen, A., Tapiola, T., Korhonen, P., & Suuronen, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00210-1 · Cited by 109
Ferrante, R. J., Kowall, N. W., Richardson, E. P., Bird, E. D., & Martin, J. B. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90634-8 · Cited by 109
Ciernia, A. V., & Wood, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.002 · Cited by 108
Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairmentsPreprint
Oliveira, A. M. M., Estévez, M. A., Hawk, J. D., Grimes, S., Brindle, P. K., & Abel, T. G. (2011) · Learning & Memory · doi:10.1101/lm.1939811 · Cited by 108
An Overview of Cytidine Deaminases
Navaratnam, N., & Sarwar, R. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06032 · Cited by 107
Epigenetic Mechanisms in Stroke and Epilepsy
Hwang, J.-Y., Aromolaran, K. A., & Zukin, R. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.134 · Cited by 105
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A
Zhou, X.-W., Gustafsson, J.-Α., Tanila, H., Björkdahl, C., Liu, R., Winblad, B. G., & Pei, J.-J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.013 · Cited by 104
Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts
Daniel, P., Brazier, M., Cerutti, I., Pieri, F., Tardivel, I., Desmet, G., Baillet, J., & Chany, C. (1989) · Clinica Chimica Acta · doi:10.1016/0009-8981(89)90231-3 · Cited by 104
Agirre, X., Román‐Gómez, J., Vázquez, I., Jiménez‐Velasco, A., Gárate, L., Montiel‐Duarte, C., Artieda-Urrutia, P., Cordeu, L., Lahortiga, I., Calasanz, M. J., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21584 · Cited by 104
Striatal histone modifications in models of levodopa‐induced dyskinesia
Nicholas, A. P., Lubin, F. D., Hallett, P. J., Vattem, P., Ravenscroft, P., Bézard, E., Zhou, S., Fox, S. H., Brotchie, J. M., Sweatt, J. D., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05417.x · Cited by 103
CSF-folate levels are decreased in late-onset AD patients
Sérot, J., Christmann, D., Dubost, T., Béné, M. C., & Faure, G. C. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170100 · Cited by 103
New and Xisting regulatory mechanisms of X chromosome inactivation
Jeon, Y., Sarma, K., & Lee, J. T. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.007 · Cited by 102
Milutinovic, S., Brown, S. E., Zhuang, Q., & Moshe Szyf, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312823200 · Cited by 102
Hu, Y., Chopra, V., Chopra, R., Locascio, J. J., Liao, Z., Ding, H., Zheng, B., Matson, W. R., Ferrante, R. J., Rosas, H. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104409108 · Cited by 102
Old Enzymes, New Tricks: Sirtuins Are NAD+-Dependent De-acylases
Hirschey, M. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.006 · Cited by 102
Evolutionary conservation and functional roles of ncRNA
Qu, Z., & Adelson, D. L. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00205 · Cited by 100
Genes and the Environment in Neurodegeneration
Coppedè, F., Mancuso, M., Siciliano, G., Migliore, L., & Murri, L. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9028-6 · Cited by 100
Ghose, J., Sinha, M., Das, E., Jana, N. R., & Bhattacharyya, N. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023837 · Cited by 98
Yang, H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.870 · Cited by 97
Psychotic Symptoms in Parkinson's Disease Patients with Dementia
Naimark, D. M. J., Jackson, E., Rockwell, E., & Jeste, D. V. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00918.x · Cited by 97
Kidd, S. K., & Schneider, J. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.010 · Cited by 96
Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease
McFarland, K. N., Das, S., Sun, T., Leyfer, D., Xia, E., Sangrey, G. R., Kuhn, A., Luthi‐Carter, R., Clark, T. W., Sadri‐Vakili, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041423 · Cited by 95
miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells
Fan, X., Liu, Y., Jiang, J., Ma, Z., Wu, H., Liu, T., Liu, M., Li, X., & Tang, H. (2010) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq026 · Cited by 95
Methylation Status and Neurodegenerative Markers in Parkinson Disease
Obeid, R., Schadt, A. A., Dillmann, U., Kostopoulos, P., Fassbender, K. C., & Herrmann, W. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.125021 · Cited by 95
Niwa, R., Zhou, F. L., Li, C., & Slack, F. J. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.12.044 · Cited by 94
MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease
Yao, J., Hennessey, T., Flynt, A. S., Lai, E. C., Beal, M. F., & Lin, M. T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015546 · Cited by 93
Marinova, Z., Leng, Y., Leeds, P. R., & Chuang, D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.022 · Cited by 93
Kaidery, N. A., Tarannum, S., & Thomas, B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0211-8 · Cited by 93
Global microRNA Expression Profiling of Caenorhabditis elegans Parkinson's Disease Models
Asikainen, S., Rudgalvyte, M., Heikkinen, L., Louhiranta, K., Lakso, M., Wong, G., & Nass, R. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9325-1 · Cited by 93
Favorite music and hand massage
Hicks-Moore, S. L., & Robinson, B. (2008) · Dementia · doi:10.1177/1471301207085369 · Cited by 92
Hyman, B. T., Elvhage, T. E., & Reiter, J. S. (1994) · PubMed Central · Cited by 92
The evolution of RNAs with multiple functions
Dinger, M. E., Gascoigne, D. K., & Mattick, J. S. (2011) · Biochimie · doi:10.1016/j.biochi.2011.07.018 · Cited by 92
Genetic and environmental risk factors in Parkinson’s disease
Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 91
Research works printed but not linked: 2
- Alarcón, 2004, Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration, Neuron, 42, 947, 10.1016/j.neuron.2004.05.021 · DOI · Paper page
- Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309
Cited by
Sorted by citations
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308
Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers
Cole, J. H., & Franke, K. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.001 · Cited by 939
β-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872
“The broader role of epigenetics in cognition and neurodegenerative disease has been reviewed (67, 68, 100).”
Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 730
Self-citation
Metadata
- Authors
- Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., & Rutten, B. P. F.
- Affiliations
- Maastricht University (NL)
- University of Lausanne (CH)
- Banner Sun Health Research Institute (US)
- Brigham and Women's Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Rutten, Bart P.F.
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 131
- Pages
- 21-64
- ISSN
- 0301-0082 (ISSN-L)
- PMC
- PMC6477921
- OpenAlex
- W648684004
- Cited by
- 381
- References
- 770
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 47 · 2020: 30 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 11
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (07551, 11532, 09552, 13515)
- Netherlands Organization for Scientific Research (916.11.086)
- National Institutes of Health (P50 AG005138)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- epigenetics, aging, neurodegeneration, DNA methylation, DNA demethylation, chromatin remodeling, non-coding RNA, Alzheimer's disease, Parkinson's disease, Huntington's disease, epigenetic therapy, gene expression regulation, histone modifications
- MeSH terms
- Aging, Animals, Humans, DNA Methylation, Neurodegenerative Diseases, Genetic Predisposition to Disease, RNA, Untranslated, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review